GGrantIndex
Sort

11,323 grants matching glioblastoma

Understanding EGF receptor activation by growth factors and oncogenic mutations

$548,181
Mark A. Lemmon · Yale University · R01 · FY2020 · CA

Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate

$548,148
Lawrence D Recht · Stanford University · R01 · FY2015 · CA

Next Generation Brain PET Imaging

$548,070
Gregory George Zaharchuk · Stanford University · R01 · FY2023 · NS

Studies of amplification in rhabdomyosarcoma

$547,922
Frederic Barr · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors

$547,857
Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2018 · CA

Targeting Tumors with NF1 Loss

$547,736
Yolanda Sanchez · Dartmouth College · R01 · FY2016 · NS

Circulating cell-free DNA methylation as an accurate tool for detection and clinical follow-up of glioma

$547,723
Houtan Noushmehr · Henry Ford Health System · R01 · FY2024 · CA

Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma

$547,687
Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning

$547,655
Kathleen Marie Schmainda · Medical College Of Wisconsin · R01 · FY2021 · CA

Magnetic-vortex microdiscs for glioma therapy

$547,634
Maciej S Lesniak · University Of Chicago · R01 · FY2012 · NS

NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)

$547,579
Elaine R Mardis · Washington University · U01 · FY2013 · GM

Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes

$547,519
Ramon Francisco Barajas · Oregon Health & Science University · R37 · FY2024 · CA

MRI fluorescence tomography for quantifying tumor receptor concentration in vivo

$547,300
Scott C Davis · Dartmouth College · R01 · FY2017 · CA

lncRNA regulation of glioblastoma progression and therapeutic resistance

$547,221
Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS

lncRNA regulation of glioblastoma progression and therapeutic resistance

$547,221
Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS

Clinical Development of Rhenium Nanoliposomes (RNL186) for Glioblastoma

$547,212
Andrew Jacob Brenner · University Of Texas Hlth Science Center · R01 · FY2023 · CA

Antibodies, B cells and resistance to human cryptococcosis

$547,115
Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2023 · AI

Ex vivo analysis of human brain tumor cells in a microvascular niche model

$546,939
Rong Fan · Yale University · R01 · FY2021 · CA

Deciphering heritability, plasticity and differentiation trajectories in gliomas via single-cell multi-omics

$546,903
Mario Luca Suva · Massachusetts General Hospital · R01 · FY2023 · CA

Deciphering heritability, plasticity and differentiation trajectories in gliomas via single-cell multi-omics

$546,900
Mario Luca Suva · Massachusetts General Hospital · R01 · FY2022 · CA

Targeting Ferritin in Glioblastoma

$546,861
Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · CA

Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier

$546,766
Ana Krtolica · Omniox, Inc. · R01 · FY2019 · CA

A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia

$546,731
Amin Arbabian · Stanford University · R01 · FY2020 · EB

Apoptosis In Neurodegenerative Disorders

$546,674
Mark Mattson · National Institute On Aging · ZIA · FY2014 · AG

RhoA and GPCR mediated transcriptional activation regulates glioblastoma

$546,415
Joan Heller Brown · University Of California, San Diego · R01 · FY2021 · CA